Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › atrial flutter

Atrial flutter

Part of Cardiac arrhythmias

Subtypes of Atrial flutter

Typical atrial flutter 1

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for atrial flutter

26 trials tracked for atrial flutter: 9 in phase 3 or 4 and 1 with published results. The most-cited published study has 4 citations.

26Trials tracked
9Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 6 Phase 3 3 Phase 2 3 Other / NA 14
  1. Phase 4 Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion Completed · 4 cited
  2. Phase 4 Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism Completed
  3. Phase 4 Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation Completed
  4. Phase 4 Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8) Completed
  5. Phase 4 Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter Completed
  6. Phase 4 Concentrations of Amiodarone in Fat Tissue During Chronic Treatment Completed
Show 20 more trials
  1. Phase 3 Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery Completed
  2. Phase 3 A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation Completed
  3. Phase 3 Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Completed
  4. Phase 2 Cardiac Electrophysiological Study Completed
  5. Phase 2 Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm Completed
  6. Phase 2 Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter Completed
  7. N/A Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter Completed
  8. N/A iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology Completed
  9. N/A An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System Completed
  10. N/A FREEZE-AFIB Post-Market Study Completed
  11. N/A Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias Completed
  12. N/A Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias Completed
  13. N/A Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation Completed
  14. N/A Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System for Treatment of Atrial and Ventricular Arrhythmias Completed
  15. N/A Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies Completed
  16. N/A Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus Completed
  17. N/A ArcticLine Feasibility Study Completed
  18. N/A Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial Completed
  19. N/A Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency Completed
  20. N/A Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography Completed

Showing the 26 most-cited and recently-updated of 26 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Atrial flutter: what the trials found

Pharmacological management of atrial flutter includes various agents. Dronedarone was associated with a lower rate of first hospitalization for cardiovascular reasons or death from any cause compared to the control group (p<0.0001) 9. While dronedarone showed a significant reduction in hospitalizations, the difference in total deaths from any cause did not reach statistical significance (p=0.18) 9. Warfarin was evaluated for stroke and bleeding; it demonstrated significantly lower rates of adjudicated stroke or systemic embolism (p=0.0114) and significantly lower rates of major bleed events (p<0.0001) compared to the comparison group, while all-cause death rates were also significantly lower (p=0.0465) 8.

Interventional procedures for atrial flutter show high efficacy in achieving conduction block and success rates. RF energy delivery for typical atrial flutter resulted in a 93.3% rate of complete bidirectional conduction block (p=0.05) with a low incidence of cardiovascular-specific adverse events within seven days (1.5%, p=0.05) 4. The use of a gold tip catheter showed significant success with the first catheter (p=0.042), though duration of energy application did not differ significantly between groups (p=0.25) 5. Long-term treatment success was observed in patients treated with gold tip catheters, showing no statistically significant difference between groups (p=0.53) 5.

Other established interventions and technologies include the use of propofol 1, beta blockers 7, dabigatran etexilate mesylate 3, fat tissue needle aspiration 6, and specialized mapping systems such as the Sphere-9 Catheter and Affera Mapping and Ablation System, which reported a 19% rate of subjects free from documented recurrence 14.

Recent results — preliminary, needs further review

  • Amiodarone weight-based dosing showed specific steady-state concentrations (p-values not provided) 10.
  • AliveCor technology was associated with lower rates of atrial arrhythmia recurrence and shorter time to treatment for recurrence compared to the control group (p=0.05) 16.
  • ArcticLine Cardiac Cryoablation Catheter showed zero primary safety events within 7 days post-procedure 20.

For the clinician treating this condition

  • Dronedarone significantly reduces the risk of hospitalization for cardiovascular reasons or death compared to standard care 9.
  • Warfarin is associated with lower rates of stroke, systemic embolism, and major bleeding in patients undergoing treatment 8.
  • RF energy delivery for typical atrial flutter achieves a high rate of complete bidirectional conduction block (93.3%) with low early adverse events 4.

AI synthesis of 12 cited trials, updated Jun 26, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Inadequate sleep duration is associated with higher risk of atrial flutter recurrence after ablation
Cardiology RCT
Inadequate sleep duration is associated with higher risk of atrial flutter recurrence after ablation Short or long sleep may increase risk of heart rhythm issues
This multicentre randomized controlled trial of 720 patients undergoing catheter ablation for atrial fibrillation found no significant assoc…
Patients with atrial fibrillation who get less than 6 hours or more than 8 hours of sleep face a higher risk of specific heart rhythm recurr…
medRxiv Jul 14, 2026
Fragmented QRS is associated with a 2.11 risk ratio for post-ablation atrial tachyarrhythmia
Cardiology Meta-analysis
Fragmented QRS is associated with a 2.11 risk ratio for post-ablation atrial tachyarrhythmia Fragmented QRS Signals Linked to Higher Risk After Heart Surgery
This meta-analysis of six cohort studies evaluates the association between fragmented QRS (fQRS) and post-ablation outcomes in patients with…
A specific heart signal called fragmented QRS may help doctors identify patients at higher risk for recurring heart rhythm issues after surg…
Jul 1, 2026
SGLT2 inhibitors provide robust prognostic benefits in heart failure with inconsistent results in post-myocardial infarction settings
Cardiology Sys. Review
SGLT2 inhibitors provide robust prognostic benefits in heart failure with inconsistent results in post-myocardial infarction settings SGLT2 inhibitors show promise for heart failure and diabetes
This narrative review examines the cardiovascular and metabolic effects of SGLT2 inhibitors, specifically empagliflozin and dapagliflozin. T…
New evidence shows how SGLT2 inhibitors may protect the heart and manage risks for patients with type 2 diabetes and heart failure.
Frontiers Jun 9, 2026
Bipolar linear PFA shows similar safety to RFA for CTI ablation in persistent atrial fibrillation
Cardiology RCT
Bipolar linear PFA shows similar safety to RFA for CTI ablation in persistent atrial fibrillation PFA Ablation Matches Old Method With Less Time
This substudy RCT compared bipolar linear pulsed field ablation (PFA) with irrigated radiofrequency ablation (RFA) in 141 patients with pers…
Doctors can treat a specific heart rhythm problem faster with new technology without making it less safe.
Apr 16, 2026

Research across Cardiac arrhythmias

Related studies from across the Cardiac arrhythmias family.

Extended rhythm monitoring identifies 64% of asymptomatic atrial fibrillation in patients on BTKi therapy
Cardiology Meta-analysis
Extended rhythm monitoring identifies 64% of asymptomatic atrial fibrillation in patients on BTKi therapy BTK Inhibitors Linked to Hidden Heart Rhythm Problem in Cancer Patients
This meta-analysis of 2839 patients with hematologic malignancies treated with Bruton's tyrosine kinase inhibitors (BTKi) found an overall a…
A meta-analysis of 2,839 patients found that 14% of atrial fibrillation cases during BTK inhibitor therapy had no symptoms.
Oct 2, 2026
Remote ischemic preconditioning reduces postoperative atrial fibrillation in patients with specific genetic risk factors
Cardiology RCT
Remote ischemic preconditioning reduces postoperative atrial fibrillation in patients with specific genetic risk factors Trial Shows Remote Ischemic Preconditioning Reduces Heart Rhythm Issues
Researchers investigated the impact of remote ischemic preconditioning on patients with a specific genetic profile undergoing coronary arter…
A new trial shows that a specific preconditioning technique may reduce the risk of heart rhythm problems after heart bypass surgery.
Oct 1, 2026
Intracardiac echocardiography is a safe, non-inferior alternative to transesophageal echocardiography for atrial fibrillation ablation
Cardiology Meta-analysis
Intracardiac echocardiography is a safe, non-inferior alternative to transesophageal echocardiography for atrial fibrillation ablation Intracardiac echocardiography shows safety and efficiency in atrial fibrillation procedures
This meta-analysis of 7,671 patients undergoing catheter ablation for atrial fibrillation found no significant difference between intracardi…
New data shows that intracardiac echocardiography is a safe and effective alternative to traditional imaging during atrial fibrillation hear…
Sep 30, 2026
Atrial fibroblast metabolic reprogramming is a candidate mechanism for multicellular atrial cardiomyopathy in atrial fibrillation
Cardiology Sys. Review
Atrial fibroblast metabolic reprogramming is a candidate mechanism for multicellular atrial cardiomyopathy in atrial fibrillation Metabolic Changes in Heart Cells May Link to Atrial Fibrillation
This narrative review evaluates atrial fibroblast metabolic reprogramming as a potential mechanism for atrial cardiomyopathy. While studies …
New research explores how changes in cell metabolism might drive heart tissue scarring and irregular heartbeats in conditions like atrial fi…
Frontiers Sep 28, 2026
Antidepressant use is associated with a 1.34 increased risk of ventricular arrhythmia and sudden cardiac death
Cardiology Meta-analysis
Antidepressant use is associated with a 1.34 increased risk of ventricular arrhythmia and sudden cardiac death Antidepressant use linked to higher risk of sudden cardiac death
This meta-analysis of 9,619,278 patients found that antidepressant use, including SSRIs and TCAs, is associated with a significantly increas…
A massive study of over 9 million people shows a link between antidepressant use and a higher risk of serious heart rhythm problems.
Sep 24, 2026
Direct oral anticoagulant therapy reduces primary outcomes in patients with atrial fibrillation and intermediate stroke risk
Cardiology RCT
Direct oral anticoagulant therapy reduces primary outcomes in patients with atrial fibrillation and intermediate stroke risk Blood Thinners Cut Stroke Risk for Some Heart Rhythm Patients
This trial evaluated the impact of direct oral anticoagulant therapy on patients with atrial fibrillation and an intermediate risk of stroke…
For people with atrial fibrillation and moderate stroke risk, blood thinners lowered the chance of stroke, bleeding, or heart-related death.
Sep 24, 2026
Ultrasound-guided venous puncture reduces composite access site complications to 0.6% in atrial fibrillation ablation
Radiology & Imaging RCT
Ultrasound-guided venous puncture reduces composite access site complications to 0.6% in atrial fibrillation ablation Ultrasound guidance reduces serious complications during heart procedure access
This multicentre randomized controlled trial of 986 patients undergoing atrial fibrillation or left atrial tachycardia catheter ablation fou…
Using ultrasound to guide vein access during heart procedures significantly lowers the risk of bleeding and other serious complications.
Sep 22, 2026
DeepSeek AI generates guideline-conforming exercise prescriptions for myocardial infarction, heart failure, and atrial fibrillation
Physical Medicine & Rehab Guideline
DeepSeek AI generates guideline-conforming exercise prescriptions for myocardial infarction, heart failure, and atrial fibrillation AI Shows Potential for Creating Heart Health Exercise Plans
This guideline-based simulation study evaluates the use of the DeepSeek model to generate exercise prescriptions for patients with myocardia…
A simulation study shows that AI can generate safe, guideline-based exercise plans for patients with heart conditions like heart failure and…
Frontiers Sep 16, 2026
Thoracic Radiotherapy Linked to 7.6% Pooled Incidence of Reported Atrial Fibrillation
Oncology Meta-analysis
Thoracic Radiotherapy Linked to 7.6% Pooled Incidence of Reported Atrial Fibrillation Thoracic radiation for cancer may increase risk of heart rhythm issues
This meta-analysis of 9 cohort-level estimates examines reported atrial fibrillation after thoracic radiotherapy in adults with thoracic mal…
New data shows that patients receiving radiation for chest cancers may face a higher risk of developing atrial fibrillation, a common heart …
Frontiers Sep 11, 2026
Composite lipid and metabolic indices show more consistent associations with atrial fibrillation recurrence than individual measures
Cardiology Sys. Review
Composite lipid and metabolic indices show more consistent associations with atrial fibrillation recurrence than individual measures Lipid Profiles May Reflect Metabolic Burden in Atrial Fibrillation
This narrative review examines the relationship between circulating lipid profiles and atrial fibrillation risk or post-ablation recurrence.…
New research suggests that lipid levels in the blood may reflect overall metabolic health rather than acting as direct causes of heart rhyth…
Frontiers Sep 3, 2026
Pulsed-field ablation shows shorter ablation times and lower phrenic nerve palsy than cryoballoon ablation
Cardiology Meta-analysis
Pulsed-field ablation shows shorter ablation times and lower phrenic nerve palsy than cryoballoon ablation Pulsed-field Ablation Shows Faster Times for Atrial Fibrillation Treatment
This meta-analysis of 2024 patients with atrial fibrillation undergoing pulmonary vein isolation compares pulsed-field ablation (PFA) to cry…
A new analysis suggests pulsed-field ablation may offer faster procedure times and lower nerve damage risks for patients with atrial fibrill…
Sep 2, 2026
Clinical risk factors including smoking and sleep apnea increase arrhythmia recurrence after atrial fibrillation ablation
Cardiology Meta-analysis
Clinical risk factors including smoking and sleep apnea increase arrhythmia recurrence after atrial fibrillation ablation Clinical risk factors linked to higher atrial fibrillation recurrence rates
This meta-analysis examined various clinical risk factors and their impact on arrhythmia recurrence in patients undergoing catheter ablation…
Specific health conditions like sleep apnea and gum disease are linked to a higher risk of heart rhythm issues returning after surgery.
Sep 1, 2026